Phase 1 Muscle Spasticity Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Completed
Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Assess the Safety and Pharmacokinetics of CHI-541 among Healthy Participants
Muscle SpasticityPainEpilepsy+1 more
10607410 CANADA INC. DBA Spectrum Therapeutics40 enrolled1 locationACTRN12619001723178
Completed
Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Assess the Safety and Pharmacokinetics of CHI-936 in Healthy Participants
Muscle SpasticityPainEpilepsy+1 more
10607410 CANADA INC. DBA Spectrum Therapeutics40 enrolled1 locationACTRN12619001450101